RARG and neuroblastoma: Previous reports indicated that increased RARγ expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells[27], here we detected ATRA or bortezomib alone can upregulate RARγ expression, while no further increase with combined treatment.